TrialAdvances in therapy2015

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).

Claus F Vogelmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.